Wacker Adds to Biologics Capacity in Germany

Wacker Chemie (Munich, Germany) says it will invest €15 million ($22 million) to expand its biopharmaceuticals manufacturing operations at Jena, Germany. The investment program will include two projects; a new manufacturing facility to go online at the end of 2009; and a new building for process development and quality control scheduled for completion in late 2008. “The new facilities will enable us to greatly accelerate our growth in the attractive biologics market,” says Gerhard Schmid, president of Wacker Fine Chemicals, the group’s...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers